Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.28) by 7.14 percent. This is a 4 percent decrease over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $50.214 million which beat the analyst consensus estimate of $49.732 million by 0.97 percent. This is a 11.37 percent increase over sales of $45.086 million the same period last year.